We are live on ! Find out more
AC

Aaron Cowen Suvretta Capital Management

AUM $5.47B
1-Year Est. Return 131.34%
 

Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.

This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+131.34%
3 Year Est. Return
+363.85%
5 Year Est. Return
+515.73%
10 Year Est. Return
+2,786.05%
AUM
$6.69B
AUM Growth
-$75.7M
Cap. Flow
-$285M
Cap. Flow %
-4.26%
Top 10 Hldgs %
37.76%
Holding
142
New
36
Increased
36
Reduced
23
Closed
20

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$255M
2
META icon
Meta Platforms (Facebook)
META
+$149M
3
TWLO icon
Twilio
TWLO
+$109M
4
CPRT icon
Copart
CPRT
+$103M
5
AAPL icon
Apple
AAPL
+$94.3M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$214M
2
DG icon
Dollar General
DG
+$212M
3
DIS icon
Walt Disney
DIS
+$212M
4
FIVE icon
Five Below
FIVE
+$147M
5
NKE icon
Nike
NKE
+$143M

Sector Composition

Rank Sector Weight
1 Healthcare 25.3%
2 Technology 23.37%
3 Consumer Discretionary 18.23%
4 Industrials 16.77%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAUT icon
101
Nautilus Biotechnolgy
NAUT
$121M
$3.18M 0.05%
314,835
+300,000
+2,022% +$3.25M
EVGO icon
102
EVgo
EVGO
$214M
$3M 0.04%
+200,000
New +$2.55M
OMEG
103
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.98M 0.04%
300,000
– –
HCAQ
104
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2.96M 0.04%
300,000
– –
EBAC
105
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$2.92M 0.04%
+300,000
New +$2.95M
ADAG
106
Adagene
ADAG
$266M
$2.77M 0.04%
204,000
– –
CANO.WS
107
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$2.49M 0.04%
+674,566
New +$3.05M
DBTX
108
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.27M 0.03%
263,600
– –
BLSA
109
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2.11M 0.03%
200,000
– –
TMPM
110
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$1.98M 0.03%
200,000
– –
SANA icon
111
Sana Biotechnology
SANA
$1.17B
$1.97M 0.03%
100,000
-567,500
-85% -$12.9M
WPF.WS
112
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
$1.61M 0.02%
774,375
– –
EOCW.U
113
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$1.5M 0.02%
+150,000
New +$1.5M
ARYD
114
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.07M 0.02%
100,000
– –
EUCR
115
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$984K 0.01%
99,999
– –
FHTX icon
116
Foghorn Therapeutics
FHTX
$420M
$896K 0.01%
84,000
– –
FLAC
117
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$854K 0.01%
87,498
– –
FSRXW
118
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$328K ﹤0.01%
+273,149
New +$251K
EBACW
119
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$95K ﹤0.01%
+100,000
New +$93K
TMPMW
120
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$61K ﹤0.01%
66,666
– –
EUCRW
121
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$35K ﹤0.01%
33,333
– –
FLACW
122
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$32K ﹤0.01%
29,166
– –
BMBL icon
123
Bumble
BMBL
$370M
– –
-643,500
Closed -$40.1M
DG icon
124
Dollar General
DG
$27.2B
– –
-1,046,810
Closed -$212M
DIS icon
125
Walt Disney
DIS
$186B
– –
-1,146,508
Closed -$212M
2 3 4
5
6

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Aaron Cowen's Q2 2021 Portfolio in Review

As of Q2 2021, Aaron Cowen held 142 positions worth $6.69B, down 1.1% from $6.76B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aaron Cowen withdrew a net $285M in Q2 2021, closing 20 positions and reducing 23 holdings. Its most notable exit was McDonald's, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Aaron Cowen opened a new position in Alphabet (Google) Class C worth $269M.

  • Aaron Cowen's largest Q2 2021 buy was Alphabet (Google) Class C: 2,143,380 shares worth $269M.
  • Aaron Cowen added most to Amazon in Q2 2021, an estimated $88.8M increase.
  • Aaron Cowen's biggest Q2 2021 reduction was Five Below, cutting an estimated $147M.
  • Aaron Cowen fully exited McDonald's in Q2 2021, selling an estimated $214M.
  • Aaron Cowen's ten largest holdings make up 38% of its $6.69B portfolio in Q2 2021.
  • Aaron Cowen opened 36 new positions and closed 20 in Q2 2021.
  • Aaron Cowen's portfolio value fell 1.1% quarter-over-quarter to $6.69B.

Based on Suvretta Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.